Targeting miR-27a/VE-cadherin interactions rescues cerebral cavernous malformations in mice
Open accessThe DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
Abstract
Cerebral cavernous malformations (CCMs) are vascular lesions predominantly developing in the central nervous system (CNS), with no effective treatments other than surgery. Loss-of-function mutation in CCM1/krev interaction trapped 1 (KRIT1), CCM2, or CCM3/programmed cell death 10 (PDCD10) causes lesions that are characterized by abnormal vascular integrity. Vascular endothelial cadherin (VE-cadherin), a major regulator of endothelial cell (EC) junctional integrity is strongly disorganized in ECs lining the CCM lesions. We report here that microRNA-27a (miR-27a), a negative regulator of VE-cadherin, is elevated in ECs isolated from mouse brains developing early CCM lesions and in cultured ECs with CCM1 or CCM2 depletion. Furthermore, we show miR-27a acts downstream of kruppel-like factor (KLF)2 and KLF4, two known key transcription factors involved in CCM lesion development. Using CD5-2 (a target site blocker [TSB]) to prevent the miR-27a/VE-cadherin mRNA interaction, we present a potential therapy to increase VE-cadherin expression and thus rescue the abnormal vascular integrity. In CCM1- or CCM2-depleted ECs, CD5-2 reduces monolayer permeability, and in Ccm1 heterozygous mice, it restores dermal vessel barrier function. In a neonatal mouse model of CCM disease, CD5-2 normalizes vasculature and reduces vascular leakage in the lesions, inhibits the development of large lesions, and significantly reduces the size of established lesions in the hindbrain. Furthermore, CD5-2 limits the accumulation of inflammatory cells in the lesion area. Our work has established that VE-cadherin is a potential therapeutic target for normalization of the vasculature and highlights that targeting miR-27a/VE-cadherin interaction by CD5-2 is a potential novel therapy for the devastating disease, CCM.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Size-selective loosening of the blood-brain barrier in claudin-5–deficient mice
Nitta, T., Hata, M., Gotoh, S., Seo, Y., Sasaki, H., Hashimoto, N., Furuse, M., & Tsukita, S. (2003) · The Journal of Cell Biology · doi:10.1083/jcb.200302070 · Cited by 1,917
VE-Cadherin and Endothelial Adherens Junctions: Active Guardians of Vascular Integrity
Giannotta, M., Trani, M., & Dejana, E. (2013) · Developmental Cell · doi:10.1016/j.devcel.2013.08.020 · Cited by 854 · cited 1×
“VE-cadherin is critical in the maintenance of vascular integrity [65], and abnormal VE-cadherin expression is seen in CCMs [28,66] (Figs 1A and 2B).”
BackgroundMutual regulation of tumour vessel normalization and immunostimulatory reprogramming
Tian, L., Goldstein, A., Wang, H., Ching Lo, H., Sun Kim, I., Welte, T., Sheng, K., Dobrolecki, L. E., Zhang, X., Putluri, N., et al. (2017) · Nature · doi:10.1038/nature21724 · Cited by 841 · cited 1×
“This is in line with the role of normalized vasculature, which benefits the treatment of tumors [72].”
BackgroundVestweber (2008) · doi:10.1161/atvbaha.107.158014 · Cited by 806
ZO-1 controls endothelial adherens junctions, cell–cell tension, angiogenesis, and barrier formation
Tornavaca, O., Chia, M., Dufton, N., Almagro, L. O., Conway, D. E., Randi, A. M., Schwartz, M. A., Matter, K., & Balda, M. S. (2015) · Journal of Cell Biology · doi:10.1083/jcb.201404140 · Cited by 585 · cited 1×
“ZO-1, together with is partner junctional adhesion molecule-A (JAM-A), acts as an essential unit for tight junction assembly and regulation of the tension between ECs and barrier integrity [68].”
BackgroundEndMT contributes to the onset and progression of cerebral cavernous malformations
Maddaluno, L., Rudini, N., Cuttano, R., Bravi, L., Giampietro, C., Corada, M., Ferrarini, L., Orsenigo, F., Papa, E., Boulday, G., et al. (2013) · Nature · doi:10.1038/nature12207 · Cited by 486 · cited 10×
“On one hand, CD5-2 inhibits vascular permeability, thus limiting a key aspect of the pathology [5,10,11].”
BackgroundInfluentialNeurons secrete miR-132-containing exosomes to regulate brain vascular integrity
Xu, B., Zhang, Y., Du, X.-F., Li, J., Zi, H.-X., Bu, J.-W., Yan, Y., Han, H., & Du, J.-L. (2017) · Cell Research · doi:10.1038/cr.2017.62 · Cited by 354 · cited 1×
“ROCK [23], TSP1 [79], TLR4 [13] directed or targeting other miRNAs involved in vascular integrity, such as miR-132 [80], may exert further additive or synergistic effects.”
BackgroundSelf-citationEndothelial TLR4 and the microbiome drive cerebral cavernous malformations
Tang, A. T., Choi, J. P., Kotzin, J. J., Yang, Y., Hong, C. C., Hobson, N., Girard, R., Zeineddine, H. A., Lightle, R., Moore, T., et al. (2017) · Nature · doi:10.1038/nature22075 · Cited by 306 · cited 7×
“ROCK [23], TSP1 [79], TLR4 [13] directed or targeting other miRNAs involved in vascular integrity, such as miR-132 [80], may exert further additive or synergistic effects.”
BackgroundMethodInfluentialSelf-citationReijerkerk, A., Lopez-Ramirez, M. A., van het Hof, B., Drexhage, J. A. R., Kamphuis, W. W., Kooij, G., Vos, J. B., van der Pouw Kraan, T. C. T. M., van Zonneveld, A. J., Horrevoets, A. J., et al. (2013) · The Journal of Neuroscience · doi:10.1523/jneurosci.3965-12.2013 · Cited by 138 · cited 1×
“In contrast, miR-125a is required for brain EC barrier formation [30].”
BackgroundJia, W., Li, H., & He, Y.-W. (2005) · Blood · doi:10.1182/blood-2005-04-1658 · Cited by 122 · cited 1×
“The Gene Set Enrichment Analysis (GSEA) revealed CD5-2 significantly down-regulated the gene sets involved in neutrophil arrest/transmigration pathways such as extracellular matrix (ECM) receptor interaction [55], focal adhesion [56], platelet homeostasis [57], and platelet-derived growth factor (PDGF) signalling [58]…”
Background
Cited by
Blood–Brain Barrier Breakdown in Alzheimer’s Disease: Mechanisms and Targeted Strategies
Alkhalifa, A. E., Al-Ghraiybah, N. F., Odum, J., Shunnarah, J. G., Austin, N., & Kaddoumi, A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242216288 · Cited by 212
Development of Novel Therapeutics Targeting the Blood–Brain Barrier: From Barrier to Carrier
Li, J., Zheng, M., Shimoni, O., Banks, W. A., Bush, A. I., Gamble, J. R., & Shi, B. (2021) · Advanced Science · doi:10.1002/advs.202101090 · Cited by 202
Self-citationMossink, B., Negwer, M., Schubert, D., & Nadif Kasri, N. (2021) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-020-03714-5 · Cited by 114
Metadata
- Authors
- Li, J., Zhao, Y., Choi, J., Ting, K. K., Coleman, P., Chen, J., Cogger, V. C., Wan, L., Shi, Z., Moller, T., Zheng, X., Vadas, M. A., & Gamble, J. R.
- Venue
- PLOS Biology
- Publisher
- Public Library of Science (PLoS)
- Published
- 2020-06-05
- Volume
- 18
- Issue
- 6
- Pages
- e3000734
- ISSN
- 1544-9173 (ISSN-L)
- 1545-7885
- OpenAlex
- W3034055926
- Cited by
- 52
- References
- 11
- FWCI
- 3.15
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Targeting miR-27a/VE-cadherin interactions rescues cerebral cavernous malformations in mice. https://app.cochat.ai/papers/10.1371/journal.pbio.3000734
- The paper
- Li, J., Zhao, Y., Choi, J., Ting, K. K., Coleman, P., Chen, J., Cogger, V. C., Wan, L., Shi, Z., Moller, T., Zheng, X., Vadas, M. A., & Gamble, J. R. (2020). Targeting miR-27a/VE-cadherin interactions rescues cerebral cavernous malformations in mice. PLOS Biology. https://doi.org/10.1371/journal.pbio.3000734
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.